COVID-19 vaccines have been the subject of speculation and anticipation for months—so why hasn’t the U.S. made more progress on vaccination? IDIES Executive Committee member, Carey Business School Associate Professor Tinglong Dai, an expert in operations management and health care analytics. Dai has closely followed the rollout of vaccines in the U.S. and shares insights on what’s working, what needs to be improved, and how the fractured and decentralized U.S. health care system might be able to prepare for future national health care crises.
“WE HAVE TO RETHINK HOW WE CONNECT VACCINES AND PEOPLE.”Tinglong Dai
Read the entire article by Saralyn Cruickshank on the HUB.